leishmaniasis

16396.   Antinori S, Calattini S, Longhi E, Bestetti G, Piolini R, Magni C, Orlando G, Gramiccia M, Acquaviva V, Foschi A, Corvasce S, Colomba C, Titone L, Parravicini C, Cascio A, Corbellino M. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Clin Infect Dis. 2007 Jun 15;44(12):1602-10.

16397.   Lew JW, Koh CK, Selvan VS, Shen E. The hunt for an elusive source of pyrexia in a foreign worker. Singapore Med J. 2007 Apr;48(4):e111-3.

16398. Mathur P, Samantaray J, Chauhan N K Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India. Indian J med Res 2005; 122(6): 485-90.

16399.  Rajasekariah GH, Smithyman AM, Gupta RK, Martin SK. The utility of exoantigens for detection of Leishmania infections. Mil Med. 2007 May;172(5):482-5. Review.

16400.   Solomon M, Baum S, Barzilai A, Scope A, Trau H, Schwartz E. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis. J Am Acad Dermatol. 2007 Apr;56(4):612-6.

16401.   Stojkovic M, Junghanss T, Krause E, Davidson RN. First case of typical Old World cutaneous leishmaniasis treated with miltefosine. Int J Dermatol. 2007 Apr;46(4):385-7.

16402.   Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK. Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med. 2007 Jun 21;356(25):2571-81.

16403.   Venazzi EA, Roberto AC, Barbosa-Tessmann IP, Zanzarini PD, Lonardoni MV, Silveira TG.  Detection of Leishmania (Viannia) DNA in blood from patients with American cutaneous leishmaniasis. Exp Parasitol. 2007 Apr;115(4):399-402.

Pathogenesis:

16404.  Carvalho LP, Passos S, Bacellar O, Lessa M, Almeida RP, Magalhaes A, Dutra WO, Gollob KJ, Machado P, de Jesus AR. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol. 2007 May;29(5):251-8.

Vaccines:

16405.  Basu R, Roy S, Walden P. HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages. J Infect Dis. 2007 May 1;195(9):1373-80.

Chemotherapy, Immunotherapy, Management & Drugs:

16406.  Pandey S, Suryawanshi SN, Nishi, Goyal N, Gupta S. Chemotherapy of leishmaniasis. Part V: Synthesis and in vitro bioevaluation of novel pyridinone derivatives. Eur J Med Chem. 2007 May;42(5):669-74.